Left unchecked, high blood pressure can lead to strokes, heart attacks, heart failure, aneurysms and kidney failure. One Minnesota-based company says it has found a way to allow physicians to pinpoint who’s at risk for hypertension before it even becomes a problem.Hypertension Diagnostics Inc. (HDII: OTCBB) began working on its blood pressure waveform analysis in 1988, working for a way to non-invasively measure the elasticity of arteries. With its HDI/PulseWave CR-2000 Research, CardioVascular Profiling System, and CVProfilors, HDI is offering researches and doctors a way to possibly start treatment earlier – whether it be by drugs, lifestyle changes, or other methods. The company said its CVProfilor is extremely sensitive to early arterial changes as well, making detection more accurate, and faster.
The company announced its third-quarter results Monday, showing a slight decrease in revenue at $469,151 for the quarter ended March 31, 2007, compared to $571,998 last year. The company had a net loss of $76,948 for the current third quarter, compared with $276,031 – which equates to a zero loss per share this year and a penny per share loss last year. Included in that net loss are non-cash charges relating to stock compensation, depreciation and stock options.
The company had a cash balance of $1,431,380. For the year so far, though, things are looking up as the company reduces expenses. With only a slight decrease in revenue (3.6 percent), the company was able to reduce its net loss by half, posting $490,433 for the nine months so far, compared with $897,175 last year.
“We are pleased with our efforts to decrease expenses which is bringing us close to break-even cash flow,” said CEO Mark N. Schwartz in a press release.
